BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4344846)

  • 21. [How to oversee the treatment of tuberculosis?].
    Germouty J; Serizay B; Demonet B; Charles A
    Sem Hop; 1970 Jun; 46(27):1911-4. PubMed ID: 4316120
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anaphylactic shock caused by Fintozid].
    Földeş I; Norbert G
    Ftiziologia; 1971; 20(4):429-31. PubMed ID: 5162280
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 24. Incidence of drug intolerance to antituberculosis chemotherapy.
    Neff TA; Coan BJ
    Dis Chest; 1969 Jul; 56(1):10-2. PubMed ID: 5789831
    [No Abstract]   [Full Text] [Related]  

  • 25. Initial treatment of tuberculosis with rifampicin.
    O'Connell J; Campbell AH; Cowen K; Verins A
    Med J Aust; 1973 Nov; 2(19):881-5. PubMed ID: 4765873
    [No Abstract]   [Full Text] [Related]  

  • 26. Side effects of drugs used to treat tuberculosis.
    Newton RW
    Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 28. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Launois-Bensaude disease; etiopathogenic discussion in a patient treated with tuberculostatic agents].
    Warembourg H; Jaillard J; Carre A; Perrard C; Ginestet A; Beuscart F
    Lille Med; 1975 Feb; 20(2):102-6. PubMed ID: 1142984
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
    Levantine A; Almeyda J
    Br J Dermatol; 1972 Jun; 86(6):651-5. PubMed ID: 4114691
    [No Abstract]   [Full Text] [Related]  

  • 31. Case of extreme hypersensitivity to almost all antituberculous drugs.
    Agrawal R
    Br Med J; 1969 Nov; 4(5682):540. PubMed ID: 5354853
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced heart failure in advanced pulmonary tuberculosis.
    Daynes G
    S Afr Med J; 1974 Nov; 48(57):2352-3. PubMed ID: 4432186
    [No Abstract]   [Full Text] [Related]  

  • 33. [Critical study of antibiotic tests systematically performed before treatment of pulmonary tuberculous patients].
    Benda R; Le Guillou F
    Sem Ther; 1965 Jan; 41(1):19-21. PubMed ID: 5879027
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 35. [Side effects of tuberculostatics (author's transl)].
    Favez G; Wiser H
    Munch Med Wochenschr; 1973 Sep; 115(39):1685-90. PubMed ID: 4801051
    [No Abstract]   [Full Text] [Related]  

  • 36. [Four drug combination including Ethambutol and early switching to entirely new regimen in initial treatment of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):219-26. PubMed ID: 5449509
    [No Abstract]   [Full Text] [Related]  

  • 37. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The hemogram and ESR in pulmonary tuberculosis during intravenous administration of the primary antitubercular drugs].
    Koviazina AI; Utkin VV
    Probl Tuberk; 1971; 49(2):48-51. PubMed ID: 5561919
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.